Skip to main content
Top
Published in: Acta Neurochirurgica 12/2014

Open Access 01-12-2014 | Clinical Article - Pediatrics

Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey

Authors: Walter Stummer, Floriano Rodrigues, Philippe Schucht, Matthias Preuss, Dorothee Wiewrodt, Ulf Nestler, Marco Stein, José Manuel Cabezudo Artero, Nunzio Platania, Jane Skjøth-Rasmussen, Alessandro Della Puppa, John Caird, Søren Cortnum, Sam Eljamel, Christian Ewald, Laura González-García, Andrew J Martin, Ante Melada, Aurelia Peraud, Angela Brentrup, Thomas Santarius, Hans Herbert Steiner, For the European ALA Pediatric Brain Tumor Study Group

Published in: Acta Neurochirurgica | Issue 12/2014

Login to get access

Abstract

Background

Five-aminolevulinic acid (Gliolan, medac, Wedel, Germany, 5-ALA) is approved for fluorescence-guided resections of adult malignant gliomas. Case reports indicate that 5-ALA can be used for children, yet no prospective study has been conducted as of yet. As a basis for a study, we conducted a survey among certified European Gliolan users to collect data on their experiences with children.

Methods

Information on patient characteristics, MRI characteristics of tumors, histology, fluorescence qualities, and outcomes were requested. Surgeons were further asked to indicate whether fluorescence was “useful”, i.e., leading to changes in surgical strategy or identification of residual tumor. Recursive partitioning analysis (RPA) was used for defining cohorts with high or low likelihoods for useful fluorescence.

Results

Data on 78 patients <18 years of age were submitted by 20 centers. Fluorescence was found useful in 12 of 14 glioblastomas (85 %), four of five anaplastic astrocytomas (60 %), and eight of ten ependymomas grades II and III (80 %). Fluorescence was found inconsistently useful in PNETs (three of seven; 43 %), gangliogliomas (two of five; 40 %), medulloblastomas (two of eight, 25 %) and pilocytic astrocytomas (two of 13; 15 %). RPA of pre-operative factors showed tumors with supratentorial location, strong contrast enhancement and first operation to have a likelihood of useful fluorescence of 64.3 %, as opposed to infratentorial tumors with first surgery (23.1 %).

Conclusions

Our survey demonstrates 5-ALA as being used in pediatric brain tumors. 5-ALA may be especially useful for contrast-enhancing supratentorial tumors. These data indicate controlled studies to be necessary and also provide a basis for planning such a study.
Literature
1.
go back to reference Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Diez-Valle R (2013) Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72(6):915–20, discussion 920–921PubMedCrossRef Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Diez-Valle R (2013) Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72(6):915–20, discussion 920–921PubMedCrossRef
2.
go back to reference Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neuro-Oncol 102(1):105–113CrossRef Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neuro-Oncol 102(1):105–113CrossRef
3.
go back to reference Haj-Hosseini N, Richter J, Andersson-Engels S, Wardell K (2010) Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. doi:10.1002/lsm.20868 PubMed Haj-Hosseini N, Richter J, Andersson-Engels S, Wardell K (2010) Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. doi:10.​1002/​lsm.​20868 PubMed
4.
go back to reference Piccirillo SGM, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C (2012) Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer 107(3):462–468PubMedCentralPubMedCrossRef Piccirillo SGM, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C (2012) Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer 107(3):462–468PubMedCentralPubMedCrossRef
5.
go back to reference Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34(3):314–317PubMed Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34(3):314–317PubMed
6.
go back to reference Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurgery 71(5):927–35, discussion 935–936PubMedCrossRef Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurgery 71(5):927–35, discussion 935–936PubMedCrossRef
7.
go back to reference Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J (2014) 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir (Wien) 156(2):305–312, discussion 312CrossRef Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J (2014) 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir (Wien) 156(2):305–312, discussion 312CrossRef
9.
go back to reference Stummer W, Tonn J-C, Goetz C, Ullrich W, Stepp H, Bink A, Pietsch T, Pichlmeier U (2014) 5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. Neurosurgery 74(3):310–9, discussion 319–320PubMedCentralPubMedCrossRef Stummer W, Tonn J-C, Goetz C, Ullrich W, Stepp H, Bink A, Pietsch T, Pichlmeier U (2014) 5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. Neurosurgery 74(3):310–9, discussion 319–320PubMedCentralPubMedCrossRef
10.
go back to reference Valdes PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, Tosteson TD, Hartov A, Ji S, Erkmen K, Simmons NE, Paulsen KD, Roberts DW (2011) Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115(1):11–17PubMedCentralPubMedCrossRef Valdes PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, Tosteson TD, Hartov A, Ji S, Erkmen K, Simmons NE, Paulsen KD, Roberts DW (2011) Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115(1):11–17PubMedCentralPubMedCrossRef
11.
go back to reference Della Puppa A, Rustemi O, Gioffre G, Troncon I, Lombardi G, Rolma G, Sergi M, Munari M, Cecchin D, Gardiman MP, Scienza R (2014) Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningiomas surgery. J Neurosurg 120(4):840–845PubMedCrossRef Della Puppa A, Rustemi O, Gioffre G, Troncon I, Lombardi G, Rolma G, Sergi M, Munari M, Cecchin D, Gardiman MP, Scienza R (2014) Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningiomas surgery. J Neurosurg 120(4):840–845PubMedCrossRef
12.
go back to reference Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger H-J, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154(2):223–228, discussion 228CrossRef Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger H-J, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154(2):223–228, discussion 228CrossRef
13.
go back to reference Valdes PA, Bekelis K, Harris BT, Wilson BC, Leblond F, Kim A, Simmons NE, Erkmen K, Paulsen KD, Roberts DW (2014) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningiomas: qualitative and quantitative measurements in vivo. Neurosurgery 10(Suppl 1):74–82, discussion 82–83PubMedCrossRef Valdes PA, Bekelis K, Harris BT, Wilson BC, Leblond F, Kim A, Simmons NE, Erkmen K, Paulsen KD, Roberts DW (2014) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningiomas: qualitative and quantitative measurements in vivo. Neurosurgery 10(Suppl 1):74–82, discussion 82–83PubMedCrossRef
14.
go back to reference Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38(2):265–271PubMedCrossRef Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38(2):265–271PubMedCrossRef
15.
go back to reference Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME (2012) Predictors of survival among pediatric and adult ependymoma cases: a study using surveillance, epidemiology, and end results data from 1973 to 2007. Neuroepidemiology 39(2):116–124PubMedCentralPubMedCrossRef Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME (2012) Predictors of survival among pediatric and adult ependymoma cases: a study using surveillance, epidemiology, and end results data from 1973 to 2007. Neuroepidemiology 39(2):116–124PubMedCentralPubMedCrossRef
16.
go back to reference Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51(2):245–250PubMedCrossRef Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51(2):245–250PubMedCrossRef
17.
go back to reference Peters O, Gnekow AK, Rating D, Wolff JEA (2004) Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr Blood Cancer 43(3):250–256PubMedCrossRef Peters O, Gnekow AK, Rating D, Wolff JEA (2004) Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr Blood Cancer 43(3):250–256PubMedCrossRef
18.
go back to reference Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick W, Debus J, Combs SE (2011) Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.12.042 Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick W, Debus J, Combs SE (2011) Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys. doi:10.​1016/​j.​ijrobp.​2010.​12.​042
19.
go back to reference Song KS, Phi JH, Cho B-K, Wang K-C, Lee JY, Kim DG, Kim IH, Ahn HS, Park S-H, Kim S-K (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6(2):145–149PubMedCrossRef Song KS, Phi JH, Cho B-K, Wang K-C, Lee JY, Kim DG, Kim IH, Ahn HS, Park S-H, Kim S-K (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6(2):145–149PubMedCrossRef
20.
go back to reference Stokland T, Liu J-F, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncol 12(12):1257–1268PubMedCentralPubMed Stokland T, Liu J-F, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncol 12(12):1257–1268PubMedCentralPubMed
21.
go back to reference Ruge JR, Liu J (2009) Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor. J Neurosurg Pediatr 4(5):484–486PubMedCrossRef Ruge JR, Liu J (2009) Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor. J Neurosurg Pediatr 4(5):484–486PubMedCrossRef
22.
go back to reference Eicker S, Sarikaya-Seiwert S, Borkhardt A, Gierga K, Turowski B, Heiroth H-J, Steiger H-J, Stummer W (2011) ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. Cent Eur Neurosurg 72(2):101–103PubMedCrossRef Eicker S, Sarikaya-Seiwert S, Borkhardt A, Gierga K, Turowski B, Heiroth H-J, Steiger H-J, Stummer W (2011) ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. Cent Eur Neurosurg 72(2):101–103PubMedCrossRef
23.
go back to reference Preuss M, Renner C, Krupp W, Christiansen H, Fischer L, Merkenschlager A, Kieß W, Müller W, Manzo N, Meixensberger J, Nestler U (2013) The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 29(8):1263–1267CrossRef Preuss M, Renner C, Krupp W, Christiansen H, Fischer L, Merkenschlager A, Kieß W, Müller W, Manzo N, Meixensberger J, Nestler U (2013) The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 29(8):1263–1267CrossRef
24.
go back to reference Barbagallo GMV, Certo F, Heiss K, Albanese V (2014) 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature. Br J Neurosurg. doi:10.3109/02688697.2014.913779 Barbagallo GMV, Certo F, Heiss K, Albanese V (2014) 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature. Br J Neurosurg. doi:10.​3109/​02688697.​2014.​913779
25.
go back to reference Beez T, Sarikaya-Seiwert S, Steiger H-J, Hanggi D (2014) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children–a technical report. Acta Neurochir (Wien). doi:10.1007/s00701-014-1997-9 Beez T, Sarikaya-Seiwert S, Steiger H-J, Hanggi D (2014) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children–a technical report. Acta Neurochir (Wien). doi:10.​1007/​s00701-014-1997-9
26.
go back to reference Schwake M, Gunes D, Kochling M, Brentrup A, Schroeteler J, Hotfilder M, Fruehwald MC, Stummer W, Ewelt C (2014) Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid. Acta Neurochir (Wien). doi:10.1007/s00701-014-2096-7 Schwake M, Gunes D, Kochling M, Brentrup A, Schroeteler J, Hotfilder M, Fruehwald MC, Stummer W, Ewelt C (2014) Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid. Acta Neurochir (Wien). doi:10.​1007/​s00701-014-2096-7
27.
go back to reference Ritz R, Scheidle C, Noell S, Roser F, Schenk M, Dietz K, Strauss WSL (2012) In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS One. doi:10.1371/journal.pone.0051974 Ritz R, Scheidle C, Noell S, Roser F, Schenk M, Dietz K, Strauss WSL (2012) In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS One. doi:10.​1371/​journal.​pone.​0051974
28.
go back to reference Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 65(6):1070–6, discussion 1076–1077PubMedCrossRef Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 65(6):1070–6, discussion 1076–1077PubMedCrossRef
29.
go back to reference Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. doi:10.1016/S1470-2045(06)70665-9 PubMed Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. doi:10.​1016/​S1470-2045(06)70665-9 PubMed
Metadata
Title
Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey
Authors
Walter Stummer
Floriano Rodrigues
Philippe Schucht
Matthias Preuss
Dorothee Wiewrodt
Ulf Nestler
Marco Stein
José Manuel Cabezudo Artero
Nunzio Platania
Jane Skjøth-Rasmussen
Alessandro Della Puppa
John Caird
Søren Cortnum
Sam Eljamel
Christian Ewald
Laura González-García
Andrew J Martin
Ante Melada
Aurelia Peraud
Angela Brentrup
Thomas Santarius
Hans Herbert Steiner
For the European ALA Pediatric Brain Tumor Study Group
Publication date
01-12-2014
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 12/2014
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-014-2234-2

Other articles of this Issue 12/2014

Acta Neurochirurgica 12/2014 Go to the issue

Clinical Article - Neurosurgical Techniques

Schwannomas of the upper extremity: analysis of 34 cases